Ovid Therapeutics Inc. (OVID) Total liabilities 2020–2025
Ovid Therapeutics Inc. (OVID) total liabilities at each fiscal year-end, per SEC filings.
$20.3MFY2025 · since FY2020: $32.3M → $20.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $20.3M | -15.3% |
| FY2024 | $23.9M | -57.4% |
| FY2023 | $56.2M | +144.6% |
| FY2022 | $23.0M | +55.4% |
| FY2021 | $14.8M | -54.2% |
| FY2020 | $32.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice